Machine Learning

GTT unveils its 2026 strategy, leveraging a new AI factory to deliver a unified platform for secure, intelligent global enterprise connectivity.

Biotech firm Northwest Biotherapeutics is opening a private clinic to speed up cancer therapy access, a strategic move to control its supply chain.

Digital Brands Group launches AVO apparel with Vanderbilt, tapping the NIL market. But can a struggling company score a win in the big leagues of college sports?

The Texas hospital is ditching manual spreadsheets for an automated system, aiming to free up doctors' time, ensure fairer workloads, and improve patient care.

A new AI-driven platform moves beyond static reports, offering continuous genomic updates to give cancer patients access to the latest treatment options.

The fast-growing Pilates franchise partners with KSM, using data-driven marketing to open 70 studios and compete in the booming boutique fitness market.

AI promises to transform drug discovery, but billions in investment are at risk. A new report reveals why the real bottleneck isn't tech, but data itself.

With a new legal chief experienced in FDA clearance, Formedics signals an aggressive push to navigate regulatory hurdles and dominate HCP engagement.

A new study reveals a nationwide failure to safeguard cognitive effort in schools, as most states allow AI to replace the struggle essential for learning.

New 'Capture AI' uses agentic OCR to bypass complex system integrations, promising massive cost savings and streamlined data capture for hospitals.

A new alliance between UltraGreen and LifeSignals will bring advanced wearable heart monitors to a global market, tackling rising cardiovascular disease.

German tech firm steute buys Minnesota's Electro-Sensors at a 75% premium, signaling a strategic push into the booming US industrial sensor market.

With a new CEO known for billion-dollar deals, Modulari-T Biosciences is poised to commercialize its next-gen in vivo cell therapy platform.

The medtech giant posts Q1 growth and secures critical EU approvals for new devices, navigating post-pandemic shifts and geopolitical headwinds with strong cash flow.

The quant firm's AI-driven event strategy lands a key institutional partner, filling half of its $1B capacity and signaling a broader Wall Street shift.

Protos Security's latest acquisition signals a major industry shift, combining nationwide guarding with elite global intelligence and executive protection.

As AI tools strain developer infrastructure, Eclipse offers enterprise-grade reliability to AWS and Google, ensuring the VS Code ecosystem remains open.

A new liquid biopsy using viral DNA gets FDA fast-track status, promising to detect liver cancer recurrence more than five months earlier than imaging scans.

With the appointment of Mike Cavan, Quest Analytics signals a major push to dominate the provider network space by leveraging deep data analytics expertise.

A UK biotech's Rincell-1 therapy enters human trials, aiming to regenerate auditory nerves and restore hearing where current technology falls short.